Fact Sheet
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety, and value in the discovery, development, and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments, and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments, and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, Pfizer has worked to make a difference for all who rely on us.
Our Company - Advancing Our Strategy (as of January 30, 2024)
$58.5 Billion
Revenues in 2023 (as of January 30, 2024)
37
Manufacturing sites worldwide
~200
Countries where we sell our products
112
Projects in our pipeline (as of January 30, 2024)
~88,000
Employees globally
9
Products with sales greater than $1B in 2023 (as of January 30, 2024)
CEO:
Albert Bourla
Global Headquarters:
66 Hudson Yards
New York, NY 10001 (USA)
Products
Every product is the result of 1,500 scientists overseeing more than 500,000 lab tests and over 36 clinical trials before the first prescription.
Our R&D Priorities and Strategy
- Delivering a pipeline of highly differentiated medicines and vaccines where we have a unique opportunity to bring the most important new therapies to patients in need
- Advancing our capabilities that can position us for long-term R&D leadership; and
- Advancing new models for partnerships with creativity, flexibility and urgency to deliver innovation to patients as quickly as possible.
[For ref: See priority bullets on p. 5 of our 10K: PFE 10K (PDF)]